| Dr Justin Michael Gamez, MD | |
|
22505 Landmark Ct # 210b, Ashburn, VA 20148-6500 | |
| (571) 612-6350 | |
| Not Available |
| Full Name | Dr Justin Michael Gamez |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 22505 Landmark Ct # 210b, Ashburn, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003296625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD467606 (Pennsylvania) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 0101279940 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
In March 2020, New York City, an icon of America, was unfortunately named an early epicenter of the novel coronavirus. Now seven months later, America faces a new surge in coronavirus cases and researchers at Texas A&M University hope to provide information and context to help with the battle ahead.
A new study published in the journal JAMA Network Open in March 2020 shows that dentists can eliminate opioid analgesia from their armory of pain reliever after a tooth extraction, or at least dramatically reduce its use.
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
› Verified 6 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20080806000696 |
News Archive
In March 2020, New York City, an icon of America, was unfortunately named an early epicenter of the novel coronavirus. Now seven months later, America faces a new surge in coronavirus cases and researchers at Texas A&M University hope to provide information and context to help with the battle ahead.
A new study published in the journal JAMA Network Open in March 2020 shows that dentists can eliminate opioid analgesia from their armory of pain reliever after a tooth extraction, or at least dramatically reduce its use.
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Michael Gamez, MD 3401 N Broad St, Philadelphia, PA 19140-5103 Ph: (215) 707-3008 | Dr Justin Michael Gamez, MD 22505 Landmark Ct # 210b, Ashburn, VA 20148-6500 Ph: (571) 612-6350 |
News Archive
In March 2020, New York City, an icon of America, was unfortunately named an early epicenter of the novel coronavirus. Now seven months later, America faces a new surge in coronavirus cases and researchers at Texas A&M University hope to provide information and context to help with the battle ahead.
A new study published in the journal JAMA Network Open in March 2020 shows that dentists can eliminate opioid analgesia from their armory of pain reliever after a tooth extraction, or at least dramatically reduce its use.
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
› Verified 6 days ago
Dr. Joilyn Stinson Martin, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 42480 Yukon Drive, Suite 100, Kaiser Permanente Ashburn Medical Center, Ashburn, VA 20147 Phone: 571-252-6000 | |
Dr. Naett Ibironke Asgill, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 43480 Yukon Dr, Ashburn, VA 20147 Phone: 571-252-6030 Fax: 571-252-6031 | |
Dr. Warner Brent Day, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 43480 Yukon Drive, Ashburn, VA 20147 Phone: 571-252-6000 | |
Dr. Cathleen O. Doane-wilson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 20925 Professional Plz, Suite 200, Ashburn, VA 20147 Phone: 703-726-9000 Fax: 703-726-9105 | |
Dr. John T Hart, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 20925 Professional Plz, Suite 100, Ashburn, VA 20147 Phone: 703-724-9694 Fax: 703-724-4017 | |
Jagdish Wadhwa, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 20925 Professional Plz, Suite 100, Ashburn, VA 20147 Phone: 703-724-4000 Fax: 703-724-4017 |